Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Mika Shimoyama"'
Autor:
Ryungsa Kim, Ami Kawai, Megumi Wakisaka, Mika Shimoyama, Naomi Yasuda, Mitsuya Ito, Takanori Kin, Koji Arihiro
Publikováno v:
Cancer Reports, Vol 6, Iss 4, Pp n/a-n/a (2023)
Abstract Background and Aim Non‐invasive breast carcinoma is considered to be localized disease and is distinguished from invasive ductal and lobular carcinomas. The local recurrence of non‐invasive carcinoma after surgery may lead to development
Externí odkaz:
https://doaj.org/article/ccbd7805abfb4e68982a50e82afa5511
Autor:
Ryungsa Kim, Ami Kawai, Megumi Wakisaka, Mika Shimoyama, Naomi Yasuda, Takanori Kin, Koji Arihiro
Publikováno v:
Cancer Reports, Vol 6, Iss 1, Pp n/a-n/a (2023)
Abstract Background Recurrence after primary treatment is an important obstacle to the curing of primary breast cancer. Less‐immunosuppressive anesthetic techniques, such as local anesthesia with lidocaine, intravenous anesthesia (IVA) with propofo
Externí odkaz:
https://doaj.org/article/1d326579373c45fbbe9ee282fd713275
Autor:
Ryungsa Kim, Ami Kawai, Megumi Wakisaka, Sayaka Sawada, Mika Shimoyama, Naomi Yasuda, Masayuki Hidaka, Yukitaka Morita, Shoichiro Ohtani, Mitsuya Ito, Kensuke Kawasaki, Takanori Kin, Koji Arihiro
Publikováno v:
Translational Oncology, Vol 14, Iss 1, Pp 100927- (2021)
Immune activation plays an important role in achieving the pathological and therapeutic effects of preoperative chemotherapy in patients with breast cancer. We evaluated how the immune response contributes to various therapeutic effects. This study w
Externí odkaz:
https://doaj.org/article/e7682bb98d63462684d461968eb0c2dc
Autor:
Ryungsa Kim, Ami Kawai, Megumi Wakisaka, Mika Shimoyama, Naomi Yasuda, Mitsuya Ito, Takanori Kin, Koji Arihiro
Publikováno v:
Cancer Reports. 6
Non-invasive breast carcinoma is considered to be localized disease and is distinguished from invasive ductal and lobular carcinomas. The local recurrence of non-invasive carcinoma after surgery may lead to development of invasive carcinoma and promo
Autor:
Yukitaka Morita, Mika Shimoyama, Sayaka Sawada, Masayuki Hidaka, Koji Arihiro, Shoichiro Ohtani, Ami Kawai, Megumi Wakisaka, Naomi Yasuda, Ryungsa Kim
Publikováno v:
European Journal of Surgical Oncology. 46:77-84
Purpose To evaluate immune responses paralleling the pathological and therapeutic effects of neoadjuvant chemotherapy (NAC) in the tumor microenvironment of breast cancer. Patients and Methods 38 patients with stages II and III breast cancer received
Autor:
Ryungsa Kim, Ami Kawai, Megumi Wakisaka, Mika Shimoyama, Naomi Yasuda, Takanori Kin, Koji Arihiro
Publikováno v:
Cancer reports (Hoboken, N.J.)REFERENCES.
Recurrence after primary treatment is an important obstacle to the curing of primary breast cancer. Less-immunosuppressive anesthetic techniques, such as local anesthesia with lidocaine, intravenous anesthesia (IVA) with propofol, and/or sedation wit
Autor:
Kensuke Kawasaki, Sayaka Sawada, Megumi Wakisaka, Ryungsa Kim, Yukitaka Morita, Takanori Kin, Mika Shimoyama, Mitsuya Ito, Ami Kawai, Shoichiro Ohtani, Masayuki Hidaka, Koji Arihiro, Naomi Yasuda
Publikováno v:
Translational Oncology, Vol 14, Iss 1, Pp 100927-(2021)
Translational Oncology
Translational Oncology
Highlights • The immune factors that determine the pathological and therapeutic effects of preoperative chemotherapy in patients with breast cancer are associated with local and systemic immune responses in the presence of tumor-infiltrating lympho
Autor:
Ryungsa Kim, Koji Arihiro, Ami Kawai, Takanori Kin, Megumi Wakisaka, Sayaka Sawada, Mika Shimoyama, Naomi Yasuda
Publikováno v:
Annals of Medicine and Surgery
Background The use of general anesthesia (GA) with inhalational anesthetics for breast cancer surgery may be associated with breast cancer recurrence and increased mortality due to the immunosuppressive effects of these drugs. Less-immunosuppressive
Autor:
Shoichiro Ohtani, Yukitaka Morita, Ami Kawai, Ryungsa Kim, Koji Arihiro, Masayuki Hidaka, Mika Shimoyama, Naomi Yasuda, Sayaka Sawada, Yuri Funaoka, Megumi Wakisaka
Publikováno v:
Journal of Clinical Oncology. 37:e12084-e12084
e12084 Background: Activation of the immune response including T lymphocytes, natural killer (NK) cells, and tumor microenvironment factors (TMEFs) is important in inducing a therapeutic response after neoadjuvant chemotherapy (NAC) in breast cancer.